Jeil Pharma Holdings, 17.1% Rise Amid COVID-19 (Nafamostat) Theme Uptrend

On the 23rd, the COVID-19 (Nafamostat) theme rose by 3.32% compared to the previous day, showing strength, while Jeil Pharma Holdings, a related stock attracting attention, surged by 17.1% compared to the previous day. Jeil Pharma Holdings is known to have converted into a holding company in June 2017.

[Graph] Major stock price changes in the COVID-19 (Nafamostat) theme

According to preliminary data compiled at 10:41, foreigners are net buying 423 shares of Jeil Pharma Holdings.

[Table] Net trading volume of foreigners and institutions (unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Jeil Pharma Holdings’ quant financial score is 24.54 points, ranking 6th within the COVID-19 (Nafamostat) theme due to higher growth and stability scores compared to the average of other related stocks. This indicates that, compared to other stocks in the theme, Jeil Pharma Holdings has a relatively fast growth rate in sales and net profit, and shows good responsiveness to changes in domestic and international economic environments.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.